Myocarditis presentation following COVID-19 virus infection versus COVID-19 vaccination
AJCD Copyright © 2022..
Coronavirus disease 2019 (COVID-19) vaccine-induced cardiac injury has recently emerged as a major public health concern around the globe. There are reported cases of COVID-19 vaccine-induced myocarditis, but they are generally extremely rare and mild. In contrast, COVID-19 infection can cause acute cardiac injury with poor prognosis and high mortality rates. Herein, we describe the difference in patients' presentation by comparing two cases of myocarditis. One after contracting COVID-19 virus infection with a severe clinical course, and the other patient developed myocarditis post-COVID-19 vaccine.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
American journal of cardiovascular disease - 12(2022), 5 vom: 22., Seite 272-277 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yendrapalli, Usha [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 02.11.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM349329451 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349329451 | ||
| 003 | DE-627 | ||
| 005 | 20231226205614.0 | ||
| 007 | tu | ||
| 008 | 231226s2022 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1164.xml |
| 035 | |a (DE-627)NLM349329451 | ||
| 035 | |a (NLM)36419861 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yendrapalli, Usha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Myocarditis presentation following COVID-19 virus infection versus COVID-19 vaccination |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Revised 02.11.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a AJCD Copyright © 2022. | ||
| 520 | |a Coronavirus disease 2019 (COVID-19) vaccine-induced cardiac injury has recently emerged as a major public health concern around the globe. There are reported cases of COVID-19 vaccine-induced myocarditis, but they are generally extremely rare and mild. In contrast, COVID-19 infection can cause acute cardiac injury with poor prognosis and high mortality rates. Herein, we describe the difference in patients' presentation by comparing two cases of myocarditis. One after contracting COVID-19 virus infection with a severe clinical course, and the other patient developed myocarditis post-COVID-19 vaccine | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID | |
| 650 | 4 | |a myocarditis | |
| 650 | 4 | |a vaccine | |
| 700 | 1 | |a Hassoun, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Zalamea, Roderick M |e verfasserin |4 aut | |
| 700 | 1 | |a Hritani, Abdulwahab |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of cardiovascular disease |d 2011 |g 12(2022), 5 vom: 22., Seite 272-277 |w (DE-627)NLM218816898 |x 2160-200X |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2022 |g number:5 |g day:22 |g pages:272-277 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2022 |e 5 |b 22 |h 272-277 | ||